High blood pressure, formally known as hypertension, is a leading cause of heart disease in the United States, impacting ...
All Patients Achieved Meaningful Decreases (Mean = 64%) in Daily Premature Ventricular Contraction Count TN-401 Gene Therapy was Well Tolerated ...
The patent-pending invention providesa new wrist-wearable patient monitoring device. In doing so, it would continuously monitor cardiac and other patient vital signs. It also provides immediate alerts ...
Compare Apple Watch, Garmin, Oura, Samsung, Withings, Huawei, and Evie Ring in the race to bring blood sugar data to ...
With the paid subscription, you also get additional benefits such as cloud storage, blood pressure monitoring, medication ...
For patients with heart failure and reduced or mildly reduced left ventricular ejection fraction, iron deficiency is common and associated with more severe symptoms, worse quality of life and an ...
Abstract: Cardiac disease remains a leading global cause of morbidity and mortality, necessitating continuous and unobtrusive monitoring of cardiac activities. Traditional contact-based ...
Advances in artificial intelligence mean today’s wearables can generate meaningful insights, not just create streams of data ...
Cardiac arrest is common and deadly, affecting up to 700 000 people in the United States annually. Advanced cardiac life support measures are commonly employed to improve outcomes. This 2025 guideline ...
Cardiovascular service line leaders are under pressure to do more with less — expand access, reduce diagnostic delays, and improve outcomes while navigating tight budgets and operational complexity.
[Image courtesy of RhythMedix] RhythMedix announced that it launched its next-generation RhythmStar SL cardiac monitoring wearable system. The launch comes more than five years after the company ...
MOUNT LAUREL, N.J., April 22, 2026 /PRNewswire/ -- RhythMedix, LLC (RhythMedix), a nationwide U.S.-based cardiac monitoring company, today announced the launch of its next-generation RhythmStar® SL ...